益普索：2025年医疗服务报告：基于对30个国家的调研（英文版）

Across 30 countries only 36% has heard about GLP-1 drugs such as Ozempic and Wegovy. However, this rises to 74% in the US. Despite much discussion about the effectiveness of the drugs, only around one in eight think there will be fewer obese people in their country in 10 years’ time. Of those that heard of the drugs, people are most likely to have been made aware of them from social media. 45% heard about GLP-1s from social media, while only 19% knew about them from a medical professional. We